Filter
1109
Text search:
molecular
testing
Featured
Recommendations
154
New Publications
233
Language
Document type
No document type
540
Guidelines
235
Studies & Reports
180
Manuals
57
Strategic & Response Plan
47
Fact sheets
24
Training Material
12
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
70
Western and Central Europe
41
Global
36
Latin America and the Carribbean
27
Africa
26
Eastern Europe
24
Kenya
23
South Africa
20
Tanzania
18
Ethiopia
17
Brazil
13
East and Southern Africa
13
West and Central Africa
13
Sierra Leone
11
Malawi
11
Russia
11
Uganda
10
Nigeria
9
Rwanda
9
Liberia
8
Philippines
8
Zambia
8
Colombia
8
South–East Asia Region
8
Asia
8
Nepal
7
Mozambique
7
Namibia
7
Peru
7
Zimbabwe
6
Bangladesh
6
Argentina
6
Senegal
5
Congo, Democratic Republic of
5
Germany
5
Indonesia
5
Ukraine
5
Myanmar / Burma
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
USA
4
Ghana
4
Pakistan
4
Syria
4
Angola
4
Guinea-Bissau
3
Cambodia
3
Eswatini/ Swaziland
3
Ecuador
3
Botswana
3
El Salvador
3
Chile
3
Vietnam
3
Spain
3
Guinea
2
Burkina Faso
2
Cameroon
2
South Sudan
2
Lebanon
2
Turkey
2
Bolivia
2
Venezuela
2
Tajikistan
2
Georgia
2
Haiti
1
Somalia
1
Jordan
1
Afghanistan
1
Gambia
1
Benin
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Guatemala
1
Lesotho
1
Mexico
1
Nicaragua
1
Palestine
1
Timor Leste/ East Timor
1
North America
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
328
Clinical Guidelines
163
Pharmacy & Technologies
52
Public Health
44
Key Resources
22
Women & Child Health
14
Capacity Building
4
Toolboxes
TB
250
COVID-19
154
AMR
81
HIV
75
NTDs
60
Rapid Response
58
Ebola
32
Mental Health
25
Planetary Health
23
Pharmacy
20
Zika
19
Refugee
13
Polio
12
NCDs
12
Specific Hazards
8
Caregiver
6
Cholera
5
Natural Hazards
4
Health Financing Toolbox
4
Disability
3
Conflict
3
Global Health Education
2
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose
...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i
...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for
...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r
...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,
...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e
...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo
...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig
...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati
...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was
...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan
...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di
...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po
...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv
...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio
...
Leptospirosis is a bacterial zoonotic disease of worldwide importance, though relatively neglected in many African countries including sub Saharan Africa that is among areas with high burden of this disease. The disease is often mistaken for other febrile illnesses such as dengue, malaria, rickettsi
...
